Moreover, Zhang et al. found that the combination of plasma CEA and miR-25 could effectively improve the accuracy for distinguishing NSCLC patients from normal controls: the AUC increased from 0.832 to 0.874, which were both better than 0.75 for CEA alone [15]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.